FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Parnell Pharmaceuticals Holdings Ltd Stock AnalysisComprehensive stock analysis for Parnell Pharmaceuticals Holdings Ltd (PARNF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPARNF
PARNF
Parnell Pharmaceuticals Holdings Ltd
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PARNF
Home🔹Stocks🔹Parnell Pharmaceuticals Holdings Ltd

Parnell Pharmaceuticals Holdings Ltd

PARNF•OTC

Parnell Pharmaceuticals Holdings Ltd

PARNF•OTC
Market cap
$1.68M
Sentiment

Your view on PARNF

Mkt Cap
$1.68M
Sentiment
Your view
PARNF
Parnell Pharmaceuticals Holdings Ltd
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PARNF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Parnell Pharmaceuticals Holdings Ltd

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Brad R. McCarthy CPA
Headquarters
Century Estate, Alexandria, NSW, AU
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Brad R. McCarthy CPA
Headquarters
Century Estate, Alexandria, NSW, AU
Description

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News